Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 1998EndocrinologyOpen Access

Antiproliferative Effect of 1 ,25-Dihydroxyvitamin D3 in Human Prostate Cancer Cell Line LNCaP Involves Reduction of Cyclin-Dependent Kinase 2 Activity and Persistent G1 Accumulation

View Full Paper
Ask AI
Bookmark
Share

Authors

SZS.-H. Zhuang

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

S.-H. Zhuang (1998) studied this question.

synapsesocial.com/papers/6a9a4ee6f7bc4aca2e45bad9https://doi.org/10.1210/en.139.3.1197
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Role of the Vitamin D Endocrine System in Health and Disease1989 · 1,039 citations
  2. 2Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation1992 · 657 citations
  3. 3Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines.1993 · 474 citations
  4. 4MOLECULAR MECHANISMS OF ACTION OF STEROID/THYROID RECEPTOR SUPERFAMILY MEMBERS1994 · 2,889 citations
  5. 5Stable expression of the nuclear vitamin D receptor in the human prostatic carcinoma cell line JCA-1: evidence that the antiproliferative effects of 1 alpha, 25-dihydroxyvitamin D3 are mediated exclusively through the genomic signaling pathway.1996 · 116 citations